Childhood Exanthems & Mumps
Parvo
Parvovirus B19
Characteristics
Icosahedral
ssDNA
Pathophysiology
Replication
Viremia
Nucleus of immature erythrocyte
Clinical
Mild illness initially
Fever
Malaise
Headache
Myalgia
Other possibilities
Splenomegaly
Lymphadenopathy
Arthralgias / Arthritis
Mild leukopenia, anemia
Itching
Slap-cheek
Confluent, indurated rash
Papular-Purpuric Gloves and Socks Syndrome (PPGSS)
Complications
Infection of fetus
Hydrops fetalis and death
Patients w/ hemoglobinopathy
Profound anemia
Aplastic crisis
Immunocompromised
Persistent infection
Persistent anemia
Diagnosis
Clinical presentation
Lab
PCR
Serology
Epidemiology
Transmission
Respiratory?
Prevention
No Vaccine
Treatment
No specific AV
I.V. Ig beneficial
Toga
Rubella
Characteristics
Pathophysiology
Respiratory tract invasion
Local replication
Viremia
Clinical
Acute illness benign
Risk damage to fetus during pregnancy
Mild illness
Low-grade fever
UR symptoms
Lymphadenopathy
Exanthem
Begins on face
Discrete
Pink-red
Fine maculopapular eruption
Enanthem
Forscheimer spots
Most common complication
Arthralgia / arthritis
Congenital rubella syndrome
Cardiac defects
Eye defects
Deafness
Hepatosplenomegaly
Growth retardation
Diagnosis
Clinical pres. NOT ENOUGH
Lab
Viral culture
Serology
Epidemiology
Transmission
Oral secretions
Incubation Period
2-3 wks
Person
Young school-aged in unvaccinated pop.
Time
Late winter, early spring
Prevention
Live attenuated vaccine
Treatment
No specific AV
Paramyxo
Measles (Rubeola)
Characteristics
Hemagglutinin
Neuraminidase
Fusion protein
Pathophysiology
Respiratory tract invasion
Local replication
Viremia
WBC
Clinical
Initially
Cough
Coryza
Conjunctivitis
Fever
Exanthem
Palms
Soles
Enanthem
Koplik spots
Complications
Pneumonia
Encephalitis
Bacterial superinfection
Otitis media
SSPE
2-10 yrs after infection
Neurologic
Diagnosis
Clinical presentation
Epidemiology
Lab
Viral culture
Immunofluorescence
Serology
Epidemiology
Transmission
Saliva, oral secretions
Incubation period
7-18 days
Person
90% attack rate
Age: Young children > 6 mo.
Time
Mainly winter & spring
1-3 year cycles
Prevention
Live attenuated vaccine
Treatment
Supportive
Vitamin A
Ribavirin
Mumps
Characteristics
Hemagglutinin
Neuraminidase
Fusion protein
Pathophysiology
Respiratory tract invasion
Local replication
Viremia
Viruria
Clinical
Fever
Swelling of salivary glands
Persists for a week
Earache or facial pain
Possible complications
CSF pleocytosis
Symptomatic meningoencephalitis
Orchitis and/or epidydmitis
(Rare) Oophoritis
(Rare) Pancreatitis
Diagnosis
Clinical presentation
Epidemiology
Lemon juice
Lab
Viral culture
Serology
Epidemiology
Transmission
Saliva, oral secretions
Incubation period
16-18 days
Person
Age: 5-15
Time
Mainly winter & spring
Prevention
Live attenuated vaccine
Treatment
No specific AV
HHV
HHV-6 (Roseola)
Clinical
High Fever (103/104)
Exanthem
Discrete irregular macules
Rose-pink
Neck, trunk
Face, extremities
2-48 hrs
Complications
Febrile seizures in infants
Diagnosis
Clinical presentation
Lab
PCR
Serology
Epidemiology
Time
Mainly fall, early spring
Incubation period
10-15 days
Prevention
No vaccine
Treatment
No treatment for Roseola
Significant reactivation disease
AV therapy